{"id":231369,"date":"2026-02-14T21:11:19","date_gmt":"2026-02-15T03:11:19","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/blood-based-tests-show-strong-promise-for-dementia-diagnosis-but-population-diversity-matters"},"modified":"2026-02-14T21:11:19","modified_gmt":"2026-02-15T03:11:19","slug":"blood-based-tests-show-strong-promise-for-dementia-diagnosis-but-population-diversity-matters","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/blood-based-tests-show-strong-promise-for-dementia-diagnosis-but-population-diversity-matters","title":{"rendered":"Blood-based tests show strong promise for dementia diagnosis\u2014but population diversity matters"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/blood-based-tests-show-strong-promise-for-dementia-diagnosis-but-population-diversity-matters2.jpg\"><\/a><\/p>\n<p>In a study <a href=\"https:\/\/www.nature.com\/articles\/s43587-025-01061-3\" target=\"_blank\">published<\/a> today, Friday, February 13, 2026, in the journal <i>Nature Aging<\/i>, researchers show that blood-based biomarkers can support accurate dementia diagnosis across diverse populations when integrated with cognitive and neuroimaging measures. Blood-based biomarkers are emerging as one of the most promising advances for the global diagnosis of dementia, including Alzheimer\u2019s disease and frontotemporal lobar degeneration. These tests offer a more accessible, scalable, and cost-effective alternative to traditional diagnostic tools such as brain imaging or cerebrospinal fluid analysis.<\/p>\n<p>However, most blood-based biomarkers have been developed and validated primarily in relatively homogeneous populations. <a href=\"https:\/\/sciencex.com\/news\/2022-04-genetic-link-routine-blood-results.html?utm_source=embeddings&utm_medium=related&utm_campaign=internal\" rel=\"related\" target=\"_blank\">Genetic background<\/a>, overall physical health, and environmental and social exposures can substantially influence biomarker levels, raising concerns about how well these tests perform across diverse populations worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a study published today, Friday, February 13, 2026, in the journal Nature Aging, researchers show that blood-based biomarkers can support accurate dementia diagnosis across diverse populations when integrated with cognitive and neuroimaging measures. Blood-based biomarkers are emerging as one of the most promising advances for the global diagnosis of dementia, including Alzheimer\u2019s disease and [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,1495,47],"tags":[],"class_list":["post-231369","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-health","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231369"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231369\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}